SEC Form 4 · accession 0001209191-16-136190
VivoSim Labs, INC. · VIVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric David
Officer — CSO & EVP Pre-Clinical Dev
Period of report
Aug 5, 2016
Accepted (ET)
Aug 9, 2016 · 6:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001497253
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 5, 2016 | S | 20,000 | $4.55 | D | 706,306 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2This number does not include 1,070,000 shares of common stock underlying outstanding options held by Dr. David; post-transaction Dr. David beneficially owns or has a right to acquire 1,776,306 shares of common stock.